December 8, 2025 - 09:00

Paul, Weiss, Rifkind, Wharton & Garrison has announced a strategic expansion of its Finance Group with the recruitment of three prominent partners: Nicholas Schwartz, Mark Adler, and Julie Ann Lamm. All three will be based in the firm's New York office, enhancing its corporate capabilities.
Nicholas Schwartz is set to join the firm before the end of the year, bringing with him a wealth of experience in finance law. Meanwhile, Mark Adler and Julie Ann Lamm have already commenced their transition to the firm, contributing their expertise to strengthen the department's offerings.
This significant addition underscores Paul Weiss's commitment to bolstering its finance practice amid a competitive legal landscape. The firm aims to leverage the extensive backgrounds of Schwartz, Adler, and Lamm to provide exceptional service to its clients and expand its influence in the finance sector. The integration of these seasoned professionals is expected to enhance the firm's reputation and capabilities in handling complex financial transactions and advisory matters.
March 17, 2026 - 05:46
Virginia joins multi-state lawsuit against OneMain FinancialVirginia has officially joined a coalition of a dozen states in filing a lawsuit against OneMain Financial, a major consumer loan company. The legal action, announced by Attorney General Jay Jones,...
March 16, 2026 - 02:28
Barclays Lifts PT on EOG Resources (EOG) to $140 From $133In a recent move underscoring confidence in the energy sector, investment bank Barclays has increased its price target for EOG Resources, Inc. The firm lifted its target to $140 per share, up from...
March 15, 2026 - 05:53
Peak War Panic Predicted to Grip Markets Within WeeksA leading market strategist warns that global financial markets are likely to experience a peak period of war-induced panic within the next one to three weeks. This forecast comes as both the...
March 14, 2026 - 22:13
A Look At Afya (NasdaqGS:AFYA) Valuation After Recent Mixed Share Price PerformanceThe valuation of Brazilian medical education leader Afya is under scrutiny following a period of mixed performance for its shares. While the stock experienced a modest single-day gain of...